Generic Capoten

Now that the patent has expired, generic Capoten is available for manufacture and sale. The generic version, which is sold under the name Captopril tablets, is currently manufactured by several drug companies, including Par Pharmaceuticals, Teva Pharmaceuticals, and Mylan Laboratories. Generic Capoten tablets are available in a range of strengths, from 12.5 mg to 100 mg.

Generic Capoten: An Overview

Capoten® (captopril) is a prescription medication that has been licensed to treat high blood pressure (hypertension), congestive heart failure, and diabetic nephropathy, along with improving survival following a heart attack. Capoten is part of a class of drugs called angiotensin-converting enzyme inhibitors, or ACE inhibitors for short. The drug helps to block the angiotensin-converting enzyme, which is normally part of a reaction in the body that causes blood vessels to narrow (constrict). By blocking this enzyme, Capoten causes blood vessels to relax, which can lower blood pressure. It also allows the heart to work more efficiently.
 
Capoten was originally developed by Bristol-Myers Squibb Company. It has since come off-patent, making it available in generic form.
 

Strengths of Generic Capoten

Generic Capoten is sold under the name Captopril tablets and is available in several strengths, including:
 
  • Captopril 12.5 mg tablets
  • Captopril 25 mg tablets
  • Captopril 50 mg tablets
  • Captopril 100 mg tablets.
     

Who Makes Generic Capoten?

Generic Capoten is currently manufactured by a number of companies, including:
 
 
  • Par Pharmaceuticals
  • Teva Pharmaceuticals
  • Mylan Laboratories
  • Sandoz.
     
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation
Referring Pages Articles